Abstract
The use of intra-articular (IA) glucocorticoids for reducing pain and inflammation in patients with osteoarthritis, rheumatoid arthritis, and other inflammatory arthropathies is widespread among primary care physicians, specialists, and non-specialists in the United States. Injectable glucocorticoids have anti-inflammatory and analgesic properties which can be effective in improving clinical parameters such as pain, range of motion, and quality of life. After injection into the IA space, glucocorticoids may be systemically absorbed; the degree of absorption can depend on the size of the joint injected, the injectable glucocorticoid preparation used, the dosage, and the frequency of the injection. The adverse effects of intra-articular glucocorticoid injections (IAGC) can often be overlooked by both the patient and physicians who administer them, in particular the potential deleterious effect on the hypothalamic–pituitary−adrenal (HPA)-axis which can result in adrenal suppression and/or iatrogenic Cushing syndrome. In this paper we provide an overview on the often under-recognized effects of IAGC on HPA-axis function.
Similar content being viewed by others
References
J.L. Hollander, E.M. Brown, R.A. Jessar, C.Y. Brown, Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone a local anti-arthritic agent. J. Am. Med. Assoc. 147(17), 1629–1635 (1951)
J.C. Snibbe, R.A. Gambardella, Use for injections in osteoarthritis in joints and sports activity. Clin. Sports Med. 24(1), 83–91 (2005)
J.R. Caldwell, Intra-articular corticosteroids. Guide for selection and indications for use. Drugs 52(4), 507–514 (1996)
O.T. Cheng, D. Souzdalnitski, B. Vrooman, J. Cheng, Evidence based knee injections for the management of arthritis. Pain. Med. 13(6), 740–753 (2012)
D.H. Neustadt, Intra-articular injections for osteoarthritis of the knee. Clev. Clin. Journ. Med. 73(10), 897–911 (2006)
M.C. Hochberg, D.L. Perlmutter, J.L. Hudson, R.D. Altman, Preferences in the management of osteoarthritis of the hip and knee:results of a survey of community based rheumatologist in the United States. Arthritis Care Res. 9(3), 170–176 (1996)
G.S. Habib, Systemic effects of intra-articular corticosteroids. Clin. Rheumatol. 28(7), 749–756 (2009)
J.M. Berthelot, B. Le Goff, Y. Maugars, Side effects of corticosteroid injections:whats new? Joint Bone Spine 80(4), 363–367 (2013)
B. Pekarek, L. Osher, S. Buck, M. Bowen, Intra-articular corticosteroid injections: a critical literature review with up-to-date findings. The Foot 21(2), 66–70 (2011)
B.J. Cole, H.R. Schumacher, Injectable corticosteroids in modern practices. J. Am. Acad. Ortho. Surg. 13(1), 37–46 (2005)
S. Ringold, P.F. Weiss, T. Beukelman, E.M. Dewitt, N.T. Llowite, Y. Kimura, R.M. Laxer, D.J. Lovell, P.A. Nigrovic, A.B. Robinson, R.K. Vehe, 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res. 65(10), 1551–1563 (2013)
B. Arroll, F. Goodyear-Smith, Corticosteroid injections for osteoarthritis of the knee:meta-analysis. BMJ 328, 869 (2004). doi:10.1136/bmj.38039.573970.7C
D.L. Scott, M. Shipley, A. Dawson, S. Edwards, D.P. Symmons, A.D. Woolf, The clinical management of rheumatoid arthritis and osteoarthritis:strategies for improving clinical effectiveness. Br. J. Rheumatol. 37(5), 546–554 (1998)
American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee (non-arthroplasty). Full guidance www.aaos.org/research/guidelines/OAKguideline.PDF; Dec 2008
A.G. Cleary, H.D. Murphy, J.E. Davidson, Intra-articular corticosteroid injections in juvenile idiopathic arthritis. Arch. Dis. Child. 88, 192–196 (2003)
N. Bellamy, J. Campbell, V. Robinson, T. Gee, R. Bourne, G. Wells, Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Coch. Data. Syst. Rev. 19(2), CD005328 (2006)
M.B. Stephens, A.I. Beutler, F.G. O’Connor, Musculoskeletal injections: a review of the evidence. Am. Fam. Physician 78(8), 971–976 (2008)
W. Lavelle, E.D. Lavelle, L. Lavelle, Intra-articular injection. Anesthesiol. Clin. 25(4), 853–862 (2007)
P. Creamer, Intra-articular corticosteroid injections in osteoarthritis:do they work and if so, how? Ann. Rheum. Dis. 56(11), 634–636 (1997)
T. Tanabe, N. Tohnai, Cyclooxygenase isozymes and their gene structures and expression. Prostag. Oth. Lip. Med. 68, 95–114 (2002)
I. Uthman, J.P. Raynauld, B. Haraoui, Intra-articular therapy in osteoarthritis. Postgrad. Med. J. 79(934), 449–453 (2003)
D. Marsland, A. Mumith, I.W. Barlow, Systemic review: the safety of intra-articular corticosteroid injection prior to total knee arthroplasty. Knee 21(1), 6–11 (2014)
D. Czock, F. Keller, F.M. Rasche, U. Haussler, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin. Pharmacokinet. 44(1), 61–98 (2005)
M.C. Lansang, T. Farmer, L. Kennedy, Diagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injections. Endocr. Pract. 15(3), 225–228 (2009)
M.C. Lansang, L.K. Hustak, Glucocorticoid-induced diabetes and adrenal suppression:how to detect and manage them. Cleve. Clin. J. Med. 78(11), 748–756 (2011)
T.D. Rozental, T.P. Sculo, Intra-articular corticosteroids: an updated overview. Am. J. Orthop. 29(1), 18–23 (2000)
H. Bergrem, The influence of uremia on pharmacokinetics and protein binding of prednisolone. Acta. Medica. Scand. 213(5), 333–337 (1983)
B.M. Frey, F.J. Frey, Clinical pharmacokinetics of prednisone and prednisolone. Clin. Pharmakokinet. 19(2), 126–146 (1990)
M. Bartoszek, A.M. Brenner, S.J. Szefler, Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Clin. Pharmacol. Ther. 42(4), 424–432 (1987)
M. Maviki, P. Cowley, H. Marmery, Injecting epidural and intra-articular triamcinolone in HIV positive patients on ritonavir:beware of iatrogenic Cushing’s syndrome. Skeletal Radiol. 42(2), 313–315 (2013)
T. Weitoft, L. Ronnblom, Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients. Ann. Rheum. Dis. 65(7), 955–957 (2006)
R.D. Armstrong, J. English, T. Gibson, J. Chakraborty, V. Marks, Serum methylprednisolone levels following intra-articular injections of methylprednisolone acetate. Ann. Rheum. Dis. 40(6), 571–574 (1981)
R.H. Straub, M. Cutolo, Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis. Viewpoint based on a systemic pathogenetic role. Arth. Rheum. 44(3), 493–507 (2001)
E.F. Morand, M. Leech, Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol. Cell Biol. 79(4), 395–399 (2001)
M. Ostergaard, P. Halberg, Intra-articular glucocorticoid injections in joint diseases. Ugeskr. Laeger 161(5), 582–586 (1999)
M. Duclos, M. Guinot, M. Colsy, F. Merle, C. Baudot, J.B. Corcuff, Y. Lebouc, High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med. Sci. Sports. Exerc. 39(7), 1036–1043 (2007)
J. Snarr, Risk, benefits and complications of epidural steroid injections:a case report. AANA J. 75(3), 183–188 (2007)
M.B. Lazarevic, J.L. Skosey, G. Djordjevic-Denic, W.I. Swedler, I. Zgardic, B.L. Myones, Reduction of cortisol levels after single intra-articular and intramuscular steroid injection. Am. J. Med. 99(4), 370–373 (1995)
H.I. Huppertz, H. Pfuller, Transient suppression of endogenous cortisol production after intra-articular steroid therapy for chronic arthritis in children. J. Rheumatol. 24(9), 1833–1837 (1997)
D.M. Reid, C. Eastmond, J.A. Rennie, Hypothalamic pituitary−adrenal axis suppression after repeated intra-articular steroid injection. Ann. Rheum. Dis. 45(1), 87 (1986)
M.M.O. Sullivan, W.R. Rumfeld, M.K. Jones, B.D. Williams, Cushing’s syndrome with suppression of the hypothalamic pituitary−adrenal axis after intra-articular steroid injections. Ann. Rheum. Dis. 44(8), 561–563 (1985)
H. Derendof, H. Mollmann, A. Gruner, D. Haack, G. Gyselby, Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin. Pharmacol. Ther. 39(3), 313–317 (1986)
R. Mader, L. Lavi, R. Luboshitzky, Evaluation of the pituitary−adrenal axis function following single intra-articular injection of methylprednisolone. Arth. Rheum. 52(3), 924–928 (2005)
K.E. Muhlendahl, B. Weber, R. Muller-Hess, S. Korth-Schutz, H. Helge, Glucocorticoids and growth hormone secretion under physiological conditions and in states of steroid excess. Eur. J. Ped. 128(2), 113–121 (1978)
E. McGuire, Sudden loss of milk supply following high dose triamcinolone (Kenacort) injection. Breastfeed. Rev. 20(1), 32–34 (2012)
T. Weitoft, A. Larsson, L. Ronnblom, Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis. Ann. Rheum. Dis. 67(3), 422–424 (2008)
M.H. Andrews, S.A. Wood, R.J. Windle, S.L. Lightman, C.D. Ingram, Acute glucocorticoid administration rapidly suppresses basal and stress induced hypothalamic-pituitary−adrenal axis activity. Endocrinology 153(1), 200–211 (2012)
D.H. Schweitzer, P.P. Le-Brun, S. Krishnaswami, H. Derendorf, Clinical and pharmacological aspects of accidental triamcinolone acetonide overdose;a case study. Neth. J. Med. 56(1), 12–16 (2000)
H.A. Bird, E.F. Ring, P.A. Bacon, A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann. Rheum. Dis. 38(1), 36–39 (1979)
M. Magnotti, M. Shimshi, Diagnosing adrenal insufficiency:which test is best-the 1 µg or the 250-µg cosyntropin stimulation test? Endocrin. Pract. 14(2), 233–238 (2008)
G. Habib, A. Jabbour, S. Artul, G. Hakim, Intra-articular methylprednisolone acetate injection at the knee joint and the hypothalamic-pituitary-adrenal axis: a randomized controlled study. Clin. Rheumatol. 33(1), 99–103 (2014)
G. Habib, S. Artul, M. Chernin, G. Hakim, A. Jabbour, The effect of intra-articular injection of betamethasone acetate/betamethasone sodium phosphate at the knee joint on the hypothalamic-pituitary-adrenal axis: a case controlled study. J. Investig. Med. 61(7), 1104–1107 (2013)
G. Habib, F. Khazin, A. Jabbour, M. Chernin, S. Badarny, J. Hakim, S. Artul, Simultaneous bilateral knee injection of methylprednisolone acetate and the hypothalamic pituitary−adrenal axis: a single blind case control study. J. Invest. Med. 62(3), 621–626 (2014)
B.M. Kudielka, C. Kirschbaum, Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneur. 28(1), 35–47 (2003)
C.J. Tornhage, Salivary cortisol for assessment of hypothalamic-pituitary-adrenal axis function. NeuroImm. Mod. 16(5), 284–289 (2009)
H. Raff, Utility of salivary cortisol measurements in Cushings syndrome and adrenal insufficiency. J. Clin. Endocrinol. Metab. 94(10), 3647–3655 (2009)
M.H. Laudat, S. Cerdas, C. Fournier, D. Guiban, B. Guilhaume, J.P. Luton, Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. J. Clin. Endocrinol. Metab. 66(2), 343–348 (1988)
W.J. Inder, G. Dimeski, A. Russell, Measurement of salivary cortisol in 2012-laboratory techniques and clinical indications. Clin. Endocrinol. 77(5), 645–651 (2012)
S. Cetinkaya, A. Ozon, N. Yordam, Diagnostic value of salivary cortisol in children with abnormal adrenal cortex functions. Horm. Res. 67(6), 301–306 (2007)
S.K. Baid, N. Sinaii, M. Wade, D. Rubino, L.K. Neiman, Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92(8), 3102–3107 (2007)
I. Perogamvros, L.J. Owen, B.G. Keevil, G. Brabant, P.J. Trainer, Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing. Clin. Endocrinol. 72(1), 17–21 (2010)
P. Restituto, J.C. Galofre, M.J. Gil, C. Mugueta, S. Santos, J.L. Monical, N. Varo, Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders. Clin. Biochem. 41(9), 688–692 (2008)
J.Y. Chon, H.S. Moon, Salivary cortisol concentration changes after epidural steroid injection. Pain. Phys. 15(6), 461–466 (2012)
J.W. Findling, H. Raff, Cushing’s syndrome:important issues in diagnosis and management. J. Clin. Endocrinol. Metab. 91(10), 3746–3753 (2006)
L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008)
G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88(12), 5593–5602 (2003)
B.J. Bloom, L.C. Miller, L.B. Tucker, A.J. Alario, J.G. Schaller, Intra-articular corticosteroids in juvenile chronic arthritis. Arthritis 39, S46 (1997)
S. Kumar, R.J. Singh, A.M. Reed, A.N. Lteif, Cushing’s syndrome after intra-articular and intradermal administration of triamcinolone acetanoiode in three pediatric patients. Pediatrics 113(6), 1820–1824 (2004)
J.S. Gondwe, J.E. Davidson, S. Deeey, J. Sills, A.G. Cleary, Secondary Cushing’s syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration. Rheumatology 44(11), 1457–1458 (2005)
T.L. Jansen, E.N.van Roon, Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection. Neth. J. Med. 60(3), 151–153 (2002)
S.M. Tuel, J.M. Meythaler, L.L. Cross, Cushing’s syndrome from epidural methylprednisolone. Pain 40(1), 81–84 (1990)
M.H. Horani, A.B. Silverberg, Secondary Cushing’s syndrome after a single epidural injection of corticosteroid. Endocr. Pract. 11(6), 408–410 (2005)
J. Kay, J.W. Findling, H. Raff, Epidural triamcinolone suppresses the pituitary-adrenal axis in human subjects. Anesth. Analg. 79(3), 501–505 (1994)
J. Leary, A. Swislocki, Hypothalamic-pituitary-adrenal suppression and iatrogenic cushing’s syndrome as a complication of epidural steroid injections. Case. Rep. Endocrinol. 2013, 617042 (2013)
C. Schwarze-Zander, D. Klingmuller, J. Klumper, C.P. Strassburg, J.K. Rockstroh, Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression:description of a new case and review of the literature. Infection 41(6), 1183–1187 (2013)
Acknowledgments
We would like to thank Amanda Mendelsohn for providing the illustration from the Center for Medical Art and Photography, Cleveland Clinic Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnston, P.C., Lansang, M.C., Chatterjee, S. et al. Intra-articular glucocorticoid injections and their effect on hypothalamic–pituitary–adrenal (HPA)-axis function. Endocrine 48, 410–416 (2015). https://doi.org/10.1007/s12020-014-0409-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0409-5